Lieff Cabraser partner Fabrice N. Vincent spoke recently with the American Bar Association (ABA) Section of Litigation about digital privacy and the seemingly unending series of hacker attacks plaguing large companies and data stores across the world. “Your Data Was Stolen But Not Your Identity (Yet),” highlights Vincent’s thoughts on cyberattacks and the challenges inherent to keeping our identities safe in an ever-changing digital landscape. [Read more…]
We are delighted to announce that Lieff Cabraser partner Fabrice N. Vincent has been reappointed Co-Chair of the American Bar Association’s Class Actions & Derivative Suits Litigation Committee. Over 1,600 attorneys strong, the Class Actions and Derivative Suits Committee consists of numerous plaintiff and defense bar practitioners, corporate counsel, and academicians interested in class actions and shareholder derivative suits. [Read more…]
In a new ruling by California’s Supreme Court, people injured outside the state can now file some claims collectively in California, broadening the right to sue for those injured outside of California by companies doing business nationwide. [Read more…]
In a significant development in the Actos litigation, the California State Appeals Court for the Second District last week reinstated a cancer patient and spouse’s $6.5 million jury award against the makers of Actos, a diabetes medication. The appellate court’s decision reaffirms the importance and role of the jury in deciding claims.
Across the nation, from Seattle to Pittsburgh to North Carolina and Florida, hospital officials have revealed that patients have tested positive for drug-resistant “superbug” bacteria after being examined with a special kind of endoscope, called a duodenoscope. At the same time, some of these same officials assert that they have no evidence the medical scopes at their facility actually transmitted the infections.